464
Views
56
CrossRef citations to date
0
Altmetric
Reviews

Oxazaphosphorines: new therapeutic strategies for an old class of drugs

, , , (Professor) , &
Pages 919-938 | Published online: 06 May 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Juan Eduardo Quiroz-Aldave, María Del Carmen Durand-Vásquez, Freddy Shanner Chávez-Vásquez, Alexandra Noelia Rodríguez-Angulo, Sonia Elizabeth Gonzáles-Saldaña, Carlos César Alcalde-Loyola, Julia Cristina Coronado-Arroyo, Francisca Elena Zavaleta-Gutiérrez, Luis Alberto Concepción-Urteaga, Juan Carlos Haro-Varas & Marcio José Concepción-Zavaleta. (2023) Ifosfamide-induced nephrotoxicity in oncological patients. Expert Review of Anticancer Therapy 0:0, pages 1-10.
Read now
Luz María Torres Espíndola, Daniela Rojo-Serrato, Antonio Álvaro-Heredia, Manuel de Jesús Castillejos López, Armando de Uña-Flores, Martin Pérez-García, Marta Zapata-Tarres, Rocio Cárdenas-Cardos, Julio Granados, Juan Luis Chávez-Pacheco, Citlaltepetl Salinas-Lara, Israel Torres-Ramirez de Arellano & Arnoldo Aquino-Gálvez. (2020) Analysis of CYP450 gene allelic variants can predict ifosfamide toxicity in Mexican paediatric patients. Biomarkers 25:4, pages 331-340.
Read now
Jing Gu, Zheng Sui, Chunshu Fang & Qunyou Tan. (2017) Stereochemical considerations in pharmacokinetic processes of representative antineoplastic agents. Drug Metabolism Reviews 49:4, pages 438-450.
Read now
Azza A. El-Sheikh, Mohamed A. Morsy & Ahmed M. Okasha. (2017) Inhibition of NF-κB/TNF-α pathway may be involved in the protective effect of resveratrol against cyclophosphamide-induced multi-organ toxicity. Immunopharmacology and Immunotoxicology 39:4, pages 180-187.
Read now

Articles from other publishers (52)

Ali Zarrabi, David Perrin, Mahboubeh Kavoosi, Micah Sommer, Serap Sezen, Parvaneh Mehrbod, Bhavya Bhushan, Filip Machaj, Jakub Rosik, Philip Kawalec, Saba Afifi, Seyed Mohammadreza Bolandi, Peiman Koleini, Mohsen Taheri, Tayyebeh Madrakian, Marek J. Łos, Benjamin Lindsey, Nilufer Cakir, Atefeh Zarepour, Kiavash Hushmandi, Ali Fallah, Bahattin Koc, Arezoo Khosravi, Mazaher Ahmadi, Susan Logue, Gorka Orive, Stevan Pecic, Joseph W. Gordon & Saeid Ghavami. (2023) Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. Cancers 15:21, pages 5269.
Crossref
Zhichao Tian & Weitao Yao. (2023) Chemotherapeutic drugs for soft tissue sarcomas: a review. Frontiers in Pharmacology 14.
Crossref
Mohammad Reza Hajinezhad, Sheida Shahraki, Zahra Nikfarjam, Fatemeh Davodabadi, Shekoufeh Mirinejad, Abbas Rahdar, Saman Sargazi & Mahmood Barani. (2023) Development of a New Vesicular Formulation for Delivery of Ifosfamide: Evidence from in vitro, in vivo, and in silico Experiments. Arabian Journal of Chemistry, pages 105086.
Crossref
Tania B. Lopez-Mendez, Raffaele Strippoli, Flavia Trionfetti, Pilar Calvo, Marco Cordani & Juan Gonzalez-Valdivieso. 2023. Cancer Nanotechnology. Cancer Nanotechnology 325 383 .
Bin Hu, Jiawei Zhu, Jianjun Shen, Liang Yang & Changlong Jiang. (2022) A Portable Sensing Platform Using an Upconversion-Based Nanosensor for Visual Quantitative Monitoring of Mesna. Analytical Chemistry 94:21, pages 7559-7566.
Crossref
Jessica Buck, Nikola Bowden & Raelene Endersby. 2022. Epigenetics and DNA Damage. Epigenetics and DNA Damage 205 225 .
Jeffrey K Aronson. (2021) When I use a word . . . . Taking therapeutic care. BMJ, pages n3010.
Crossref
M. van der Perk, Linda Broer, Yutaka Yasui, Leslie Robison, Melissa Hudson, Joop Laven, Helena van der Pal, Wim Tissing, Birgitta Versluys, Dorine Bresters, Gertjan Kaspers, Andrica de Vries, Cornelis Lambalk, Annelies Overbeek, Jacqueline Loonen, Catharina Beerendonk, Julianne Byrne, Claire Berger, Eva Clemens, Uta Dirksen, Jeanette Falck Winther, Sophie Fosså, Desiree Grabow, Monica Muraca, Melanie Kaiser, Tomáš Kepák, Jarmila Kruseova, Dalit Modan-Moses, Claudia Spix, Oliver Zolk, Peter Kaatsch, Jesse Krijthe, Leontien Kremer, Russell Brooke, Jessica Baedke, Ron van Schaik, John van den Anker, André Uitterlinden, Annelies Bos, Flora van Leeuwen, Eline van Dulmen-den Broeder, Anne-Lotte van der Kooi & Marry van den Heuvel-Eibrink. (2021) Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study. Cancers 13:18, pages 4598.
Crossref
Vicente Candela-Noguera, Gema Vivo-Llorca, Borja Díaz de Greñu, María Alfonso, Elena Aznar, Mar Orzáez, María Dolores Marcos, Félix Sancenón & Ramón Martínez-Máñez. (2021) Gene-Directed Enzyme Prodrug Therapy by Dendrimer-Like Mesoporous Silica Nanoparticles against Tumor Cells. Nanomaterials 11:5, pages 1298.
Crossref
Lukasz Dobrek, Klaudia Nalik-Iwaniak & Zbigniew Arent. (2020) The Effectiveness of N-acetylcysteine in Alleviating Kidney Dysfunction in Ifosfamide-treated Rats. The Open Urology & Nephrology Journal 13:1, pages 21-31.
Crossref
Nurhan ATİLLA & Gözde YILDIRIM ÇETİN. (2020) Evaluation of mean platelet volume before and after cyclophosphamide treatment in systemic sclerosis associated interstitial lung disease. Journal of Surgery and Medicine 4:8, pages 682-684.
Crossref
Julia Delahousse, Charles Skarbek, Mélanie Desbois, Jean-Luc Perfettini, Nathalie Chaput & Angelo Paci. (2020) Oxazaphosphorines combined with immune checkpoint blockers: dose-dependent tuning between immune and cytotoxic effects. Journal for ImmunoTherapy of Cancer 8:2, pages e000916.
Crossref
Yahdiana Harahap, Arry Yanuar, Cyril Muhammad, Madeline Melhan & Denni Joko Purwanto. (2020) Quantification of 3-Hydroxypropyl Mercapturic Acid in the Urine of Patients with Breast Cancer to Monitor Cyclophosphamide Toxicity. Therapeutic Drug Monitoring 42:4, pages 548-553.
Crossref
Georg Voelcker. (2020) Causes and possibilities to circumvent cyclophosphamide toxicity. Anti-Cancer Drugs 31:6, pages 617-622.
Crossref
Helena Muley, Rut Fadó, Rosalía Rodríguez-Rodríguez & Núria Casals. (2020) Drug uptake-based chemoresistance in breast cancer treatment. Biochemical Pharmacology 177, pages 113959.
Crossref
Tailini J.R. Stoffel, Ana L. Segatto, Monica M. Silva, Alessandro Prestes, Nilda B.V. Barbosa, João B.T. Rocha & Elgion L.S. Loreto. (2020) Cyclophosphamide in Drosophila promotes genes and transposable elements differential expression and mitochondrial dysfunction. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 230, pages 108718.
Crossref
Wannada Laisuan, Prapaporn Pisitkun, Pintip Ngamjanyaporn, Thanitta Suangtamai & Porpon Rotjanapan. (2020) Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-γ Autoantibodies. Open Forum Infectious Diseases 7:2.
Crossref
S. Lau, R. Rangarajan, C. Philidet, A. Krüger-Genge, S. Braune, S. Kammerer, J.-H. Küpper, A. Lendlein & F. Jung. (2020) Effects of acrolein in comparison to its prodrug cyclophosphamide on human primary endothelial cells in vitro. Toxicology in Vitro 62, pages 104685.
Crossref
E. Enemor Christopher, Ugwu Malachy & Nworu Chukwuemeka. (2019) Evaluation of the immunomodulatory properties and microbial bioburden of three commercial herbal mixtures sold in Awka, Anambra State Nigeria. African Journal of Pharmacy and Pharmacology 13:17, pages 297-313.
Crossref
Mehdi Yoosefian, Sakineh Sabaei & Nazanin Etminan. (2019) Encapsulation efficiency of single-walled carbon nanotube for Ifosfamide anti-cancer drug. Computers in Biology and Medicine 114, pages 103433.
Crossref
Ahmed Abdelfattah-Hassan, Shimaa I. Shalaby, Safaa I. Khater, Eman S. El-Shetry, Hosny Abd El Fadil & Shafika A. Elsayed. (2019) Panax ginseng is superior to vitamin E as a hepatoprotector against cyclophosphamide-induced liver damage. Complementary Therapies in Medicine 46, pages 95-102.
Crossref
Amanda Pereira da Costa Araújo, Carlos Mesak, Mateus Flores Montalvão, Ítalo Nascimento Freitas, Thales Quintão Chagas & Guilherme Malafaia. (2019) Anti-cancer drugs in aquatic environment can cause cancer: Insight about mutagenicity in tadpoles. Science of The Total Environment 650, pages 2284-2293.
Crossref
Michael D. Delost, David T. Smith, Benton J. Anderson & Jon T. Njardarson. (2018) From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles. Journal of Medicinal Chemistry 61:24, pages 10996-11020.
Crossref
A. Krüger-Genge, S. Steinbrecht, J.-H. Küpper, A. Lendlein & F. Jung. (2018) Evidence for cytostatic effect of cyclophosphamide on human vein endothelial cells in cancer therapy: Preliminary in vitro results. Clinical Hemorheology and Microcirculation 69:1-2, pages 267-276.
Crossref
Goran Gajski, Carina Ladeira, Marko Gerić, Vera Garaj-Vrhovac & Susana Viegas. (2018) Genotoxicity assessment of a selected cytostatic drug mixture in human lymphocytes: A study based on concentrations relevant for occupational exposure. Environmental Research 161, pages 26-34.
Crossref
Matjaž Novak, Bojana Žegura, Barbara Modic, Ester Heath & Metka Filipič. (2017) Cytotoxicity and genotoxicity of anticancer drug residues and their mixtures in experimental model with zebrafish liver cells. Science of The Total Environment 601-602, pages 293-300.
Crossref
Charles Skarbek, Julia Delahousse, Catherine Pioche-Durieu, Sonia Baconnais, Alain Deroussent, Patrice Renevret, Michael Rivard, Didier Desmaele, Thierry Martens, Eric Le Cam, Patrick Couvreur & Angelo Paci. (2017) Poly-isoprenylated ifosfamide analogs: Preactivated antitumor agents as free formulation or nanoassemblies. International Journal of Pharmaceutics 532:2, pages 748-756.
Crossref
Philip C. Burcham. (2016) Acrolein and Human Disease: Untangling the Knotty Exposure Scenarios Accompanying Several Diverse Disorders. Chemical Research in Toxicology 30:1, pages 145-161.
Crossref
Obeid M. Malekshah, Xuguang Chen, Alireza Nomani, Siddik Sarkar & Arash Hatefi. (2016) Enzyme/Prodrug Systems for Cancer Gene Therapy. Current Pharmacology Reports 2:6, pages 299-308.
Crossref
Matthias Kroiss, Timo Deutschbein, Wiebke Schlötelburg, Cristina L. Ronchi, Bruno Neu, Hans-Helge Müller, Marcus Quinkler, Stefanie Hahner, Anke Heidemeier & Martin Fassnacht. (2016) Salvage Treatment of Adrenocortical Carcinoma with Trofosfamide. Hormones and Cancer 7:3, pages 211-218.
Crossref
William D. Hedrich, Jingwei Xiao, Scott Heyward, Yao Zhang, Junran Zhang, Maria R. Baer, Hazem E. Hassan & Hongbing Wang. (2016) Activation of the Constitutive Androstane Receptor Increases the Therapeutic Index of CHOP in Lymphoma Treatment. Molecular Cancer Therapeutics 15:3, pages 392-401.
Crossref
Gareth J. Veal, Michael Cole, Girish Chinnaswamy, Julieann Sludden, David Jamieson, Julie Errington, Ghada Malik, Christopher R. Hill, Thomas Chamberlain & Alan V. Boddy. (2016) Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma. European Journal of Cancer 55, pages 56-64.
Crossref
Luz-María Torres, Liliana Rivera-Espinosa, Juan L. Chávez-Pacheco, Carlos F. Navas, Joel A. Demetrio, Radamés Alemón-Medina, Francisca Trujillo, Martín Pérez, Martha M. Zapata, Rocío Cárdenas, Citlaltepetl Salinas, Arnoldo Aquino, Rafael Velázquez-Cruz & Manuel-de-Jesús Castillejos. (2015) A New Method to Quantify Ifosfamide Blood Levels Using Dried Blood Spots and UPLC-MS/MS in Paediatric Patients with Embryonic Solid Tumours. PLOS ONE 10:11, pages e0143421.
Crossref
Borje S. Andersson, Benigno C. Valdez & Roy B. Jones. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation 211 224 .
Daniel J. Conklin, Petra Haberzettl, Ganapathy Jagatheesan, Shahid Baba, Michael L. Merchant, Russell A. Prough, Jessica D. Williams, Sumanth D. Prabhu & Aruni Bhatnagar. (2015) Glutathione S-transferase P protects against cyclophosphamide-induced cardiotoxicity in mice. Toxicology and Applied Pharmacology 285:2, pages 136-148.
Crossref
Alain Deroussent, Charles Skarbek, Adeline Maury, Hubert Chapuis, Estelle Daudigeos-Dubus, Ludivine Le Dret, Sylv?re Durand, Patrick Couvreur, Didier Desma?le & Angelo Paci. (2015) Simultaneous quantification of preactivated ifosfamide derivatives and of 4-hydroxyifosfamide by high performance liquid chromatography?tandem mass spectrometry in mouse plasma and its application to a pharmacokinetic study. Journal of Chromatography B 992, pages 30-35.
Crossref
Charles Skarbek, Lea L. Lesueur, Hubert Chapuis, Alain Deroussent, Catherine Pioche−Durieu, Aurore Daville, Joachim Caron, Michael Rivard, Thierry Martens, Jean-Rémi Bertrand, Eric Le Cam, Gilles Vassal, Patrick Couvreur, Didier Desmaele & Angelo Paci. (2014) Preactivated Oxazaphosphorines Designed for Isophosphoramide Mustard Delivery as Bulk Form or Nanoassemblies: Synthesis and Proof of Concept. Journal of Medicinal Chemistry 58:2, pages 705-717.
Crossref
Stéphane Puyo, Danièle Montaudon & Philippe Pourquier. (2014) From old alkylating agents to new minor groove binders. Critical Reviews in Oncology/Hematology 89:1, pages 43-61.
Crossref
William H. FissellIVIV & Marc Earl. 2014. Renal Disease in Cancer Patients. Renal Disease in Cancer Patients 251 269 .
Sandra Travica, Klaus Pors, Paul M. Loadman, Steven D. Shnyder, Inger Johansson, Mohammed N. Alandas, Helen M. Sheldrake, Souren Mkrtchian, Laurence H. Patterson & Magnus Ingelman-Sundberg. (2013) Colon Cancer–Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins. Clinical Cancer Research 19:11, pages 2952-2961.
Crossref
Giovanni Puccio, Paolo Brambilla, Matteo Conti, Desirée Bartolini, Douglas Noonan & Adriana Albini. (2013) Surface-activated chemical ionization-electrospray mass spectrometry in the analysis of urinary thiodiglycolic acid. Rapid Communications in Mass Spectrometry 27:3, pages 476-480.
Crossref
Stephanie L. MacAllister, Nicolas Martin-Brisac, Vincent Lau, Kai Yang & Peter J. O’Brien. (2013) Acrolein and chloroacetaldehyde: An examination of the cell and cell-free biomarkers of toxicity. Chemico-Biological Interactions 202:1-3, pages 259-266.
Crossref
Duan WangLinhao LiHui YangStephen S. Ferguson, Maria R. Baer, Ronald B. Gartenhaus & Hongbing Wang. (2013) The constitutive androstane receptor is a novel therapeutic target facilitating cyclophosphamide-based treatment of hematopoietic malignancies. Blood 121:2, pages 329-338.
Crossref
Moustapha Hassan & Borje S Andersson. (2013) Role of pharmacogenetics in busulfan/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation. Pharmacogenomics 14:1, pages 75-87.
Crossref
Anne-Charlotte Dubbelman, Hilde Rosing, Jan HM Schellens & Jos H Beijnen. (2011) Bioanalytical aspects of clinical mass balance studies in oncology. Bioanalysis 3:23, pages 2637-2655.
Crossref
Philippe Pourquier. (2011) Agents alkylants. Bulletin du Cancer 98:11, pages 1237-1251.
Crossref
Kristiina M. Huttunen, Hannu Raunio & Jarkko Rautio. (2011) Prodrugs—from Serendipity to Rational Design. Pharmacological Reviews 63:3, pages 750-771.
Crossref
Giancarlo Aldini, Marica Orioli & Marina Carini. (2011) Protein modification by acrolein: Relevance to pathological conditions and inhibition by aldehyde sequestering agents. Molecular Nutrition & Food Research 55:9, pages 1301-1319.
Crossref
Duan Wang, Linhao Li, Jennifer Fuhrman, Stephen Ferguson & Hongbing Wang. (2011) The Role of Constitutive Androstane Receptor in Oxazaphosphorine-Mediated Induction of Drug-Metabolizing Enzymes in Human Hepatocytes. Pharmaceutical Research 28:8, pages 2034-2044.
Crossref
Lidia Mazur, Małgorzata Opydo-Chanek & Marta Stojak. (2011) Glufosfamide as a new oxazaphosphorine anticancer agent. Anti-Cancer Drugs 22:6, pages 488-493.
Crossref
L.L. SWYSTUN, S. MUKHERJEE, M. LEVINE & P.C. LIAW. (2011) The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal‐based and cell‐based models. Journal of Thrombosis and Haemostasis 9:4, pages 767-775.
Crossref
Alain Deroussent, St?phanie Rodriguez, Sonia Martelli, Atmane Seck, Estelle Dubus-Daudigeos, Didier Desma?le, Gilles Vassal & Angelo Paci. (2011) Quantification of dimethyl-ifosfamide and its N-deschloropropylated metabolites in mouse plasma by liquid chromatography?tandem mass spectrometry. Journal of Chromatography B 879:11-12, pages 743-750.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.